Campbell & Co Investment Adviser’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,621	Closed	-$274K	–	611
2019 Q4	$274K	Buy	+2,621	New	+$294K	0.08%	461
2017 Q2	–	Sell	-2,514	Closed	-$304K	–	382
2017 Q1	$304K	Buy	+2,514	New	+$308K	0.79%	46

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Campbell & Co Investment Adviser's GWPH Position: Q1 2020 in Review

Campbell & Co Investment Adviser sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 2,621 shares — an estimated $274K sold.

Campbell & Co Investment Adviser first reported a position in GWPH in Q1 2017 and held it in 2 quarters. The position peaked at $304K in Q1 2017. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Campbell & Co Investment Adviser reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Campbell & Co Investment Adviser sold 2,621 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $274K.
Campbell & Co Investment Adviser first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 2 quarters.
Campbell & Co Investment Adviser's GW Pharmaceuticals Plc American Depositary Shares position peaked at $304K in Q1 2017.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2020, filed 29 Apr 2020.